Iona Walton
Tofacitinib under the spotlight after FDA warning
Data from the US raises concerns for people with ulcerative colitis taking high doses of JAK inhibitor tofacitinib, which is also approved for rheumatoid arthritis. Continue reading
Rheumatoid arthritis may start in the lungs or mouth says new research
Environmental factors in the lungs and mouth could ultimately lead to rheumatoid arthritis, says research presented at the 2019 Rheumatology Nurses Society Annual Conference. Continue reading
Yoga improves pain, function and stiffness of knee arthritis
Yoga appears to be effective for lowering pain and stiffness of knee osteoarthritis, and improving function, says a Current Rheumatology Reports paper.
Continue reading
New drug filgotinib may offer hope to some people with rheumatoid arthritis
People with rheumatoid arthritis who have an inadequate response to biologic DMARDs may enjoy improved signs and symptoms after receiving daily doses of filgotinib, experts report in the Journal of the American Medical Association. Continue reading
Reverse shoulder replacement surgery success in rheumatoid arthritis
Rheumatoid arthritis has been associated with poor outcomes when it comes to traditional shoulder replacement surgery. Continue reading
